Clinical Trial Details
| Trial ID: | L5642 |
| Source ID: | NCT01665352 |
| Associated Drug: | Ttp054 |
| Title: | A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes Mellitus |
| Interventions: | DRUG: TTP054|DRUG: Placebo |
| Outcome Measures: | Primary: Change from baseline in HbA1c (%) as compared to placebo, Day 1 to Day 84 | Secondary: Change from baseline in fasting plasma glucose (mg/dL), Day 1, Day 14, Day 28, Day 56 and Day 84|Subject achievement of HbA1c <7%, Day 84|Change from baseline in body weight, Day 1, Day 14, Day 28, Day 56 and Day 84|Subject achievement of body weight loss ≥ 2%, Day 1 and Day 84 |
| Sponsor/Collaborators: | Sponsor: vTv Therapeutics |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE2 |
| Enrollment: | 186 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT |
| Start Date: | 2012-08 |
| Completion Date: | 2013-05 |
| Results First Posted: | |
| Last Update Posted: | 2017-02-10 |
| Locations: | Site 18, Chula Vista, California, 91911, United States|Site 1, Los Angeles, California, 90057, United States|Site 13, Denver, Colorado, 80220, United States|Site 4, Coral Gables, Florida, 33134, United States|Site 5, Port Orange, Florida, 32127, United States|Site 3, Honolulu, Hawaii, 96814, United States|Site 17, Indianapolis, Indiana, 46254, United States|Site 7, Louisville, Kentucky, 40213, United States|Site 8, Auburn, Maine, 04210, United States|Site 9, Las Vegas, Nevada, 89101, United States|Site 26, Trenton, New Jersey, 08611, United States|Site 12, Rochester, New York, 14609, United States|Site 14, Cincinnati, Ohio, 45219, United States|Site 6, Mount Pleasant, South Carolina, 29464, United States|Site 16, Dallas, Texas, 75230, United States|Site 10, Houston, Texas, 77072, United States|Site 2, Houston, Texas, 77074, United States|Site 11, Katy, Texas, 77450, United States|Site 15, Richmond, Virginia, 23294, United States |
| URL: | https://clinicaltrials.gov/show/NCT01665352 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|